Training in the genetic basis of pediatric gastrointestinal disorders: The revolutions in genetics and genomics have led to discoveries in a range of GI diseases, many of which affect the health of children. Pediatric gastroenterologists who are trained in genetic research will be essential in the effort to identify novel genetic cause of GI disease, reveal their molecular mechanisms, and translate them into therapy. The outstanding laboratory, translational, and clinical research at CHOP and the Perelman School of Medicine (PSOM) present an ideal environment for research career development in the genetics of pediatric GI disease. The overarching goals of the this training program are to: Train a cadre of committed researchers to investigate the genetic basis of pediatric GI disease and to use this knowledge to improve the health of children and adults. Provide these individuals with the skill sets and foundation for career advancement. Encourage innovation and leadership in academic pediatric GI.
The Specific Aims of this training program are to: Identify, recruit and foster the career development of post-doctoral research trainees from the pool of CHOP GI fellows, PSOM GI fellows, and other scientists committed to training and career development in the genetics of pediatric gastrointestinal disease. Match trainee strengths and interests with mentoring teams. Provide intensive mentored research experience and training with dedicated faculty. Provide career mentoring, including training on successful grant and manuscript preparation. Bring together faculty and fellows through seminar series and other academic activities to create a collaborative community of physician-scientists. Provide guidance for structured learning opportunities on the principles of genetic research, including research ethics and the protection of animal and human subjects. To achieve these goals, we have designed a training program comprising: Two years of support per trainee, with a total of 4 training slots each year (2 slots in the first year). Mentored independent research with a team approach and scholarship oversight. Career mentoring including individualized independent development plans (IDP), seminars and workshops focusing on professional development and career advancement skills. Didactic opportunities designed to provide specific research skills. Seminars, workshops and journal clubs focusing on research and progress in the field.

Public Health Relevance

Children are affected by a wide variety of diseases that impact the gastrointestinal system. The goal of this program is to train post-MD and -PhD researchers at the Children?s Hospital of Philadelphia and the Perelman School of Medicine to successfully pursue careers dedicated to investigating the genetic basis of pediatric gastrointestinal, liver, and nutritional disease, and to using that knowledge to improve the health of children and adults.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK101371-02
Application #
8883521
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
2014-07-01
Project End
2019-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
2
Fiscal Year
2015
Total Cost
$136,358
Indirect Cost
$9,434
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Fahey, Lisa M; Guzek, Ryan; Ruffner, Melanie A et al. (2018) EMSY is increased and activates TSLP & CCL5 expression in eosinophilic esophagitis. Pediatr Allergy Immunol 29:565-568
Fahey, Lisa M; Chandramouleeswaran, Prasanna M; Guan, Shaobo et al. (2018) Food allergen triggers are increased in children with the TSLP risk allele and eosinophilic esophagitis. Clin Transl Gastroenterol 9:139
Estrada, Michelle A; Zhao, Xiao; Lorent, Kristin et al. (2018) Synthesis and Structure-Activity Relationship Study of Biliatresone, a Plant Isoflavonoid That Causes Biliary Atresia. ACS Med Chem Lett 9:61-64
Kim, Dorothy; Hofstaedter, Casey E; Zhao, Chunyu et al. (2017) Optimizing methods and dodging pitfalls in microbiome research. Microbiome 5:52
Conrad, Máire A; Dawany, Noor; Sullivan, Kathleen E et al. (2017) Novel ZBTB24 Mutation Associated with Immunodeficiency, Centromere Instability, and Facial Anomalies Type-2 Syndrome Identified in a Patient with Very Early Onset Inflammatory Bowel Disease. Inflamm Bowel Dis 23:2252-2255
Koo, Kyung A; Waisbourd-Zinman, Orith; Wells, Rebecca G et al. (2016) Reactivity of Biliatresone, a Natural Biliary Toxin, with Glutathione, Histamine, and Amino Acids. Chem Res Toxicol 29:142-9
Waisbourd-Zinman, Orith; Koh, Hong; Tsai, Shannon et al. (2016) The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology 64:880-93
Zhao, Xiao; Lorent, Kristin; Wilkins, Benjamin J et al. (2016) Glutathione antioxidant pathway activity and reserve determine toxicity and specificity of the biliary toxin biliatresone in zebrafish. Hepatology 64:894-907
Lorent, Kristin; Gong, Weilong; Koo, Kyung A et al. (2015) Identification of a plant isoflavonoid that causes biliary atresia. Sci Transl Med 7:286ra67